EFFECTS OF TRIMETHYLAMINE-N-OXIDE INHIBITOR IN COMBINATION WITH ANTICHOLINESTERASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Aim. Assessment of Ipigrix effectiveness (patented name of Ipidacrine) taking as a self-administered and in combination with Mildronate (patented name of Meltedonium) in patients with type 2 diabetes mellitus suffering from diabetic polyneuropathy, diabetic encephalopathy, ischaemic heart disease, a...

Full description

Bibliographic Details
Main Authors: Olesya Kikhtyak, Khrystyna Moskva, Orysia Lishchuk
Format: Article
Language:English
Published: Shevchenko Scientific Society 2018-06-01
Series:Праці Наукового товариства імені Шевченка. Медичні науки
Subjects:
Online Access:https://mspsss.org.ua/index.php/journal/article/view/130